packageReslizumab

reslizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Reslizumab is a monoclonal antibody used as an antiasthmatic medicine for asthma. It is authorised in the European Union for asthma and remains in use, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q7315650 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:reslizumab
ATC codes:R03DX08
DrugBank:DB06602
Wikidata:Q7315650
molar mass:147000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown